Clinical Trials
35 trialsNCT04537156 2025-11-21
Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
Xiamen University
Phase 3 Active not recruiting
NCT03493542 2024-12-31
V501-213
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT03721978 2024-10-17
REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
Inovio Pharmaceuticals
Phase 3 Completed
NCT03185013 2023-07-27
REVEAL 1
Inovio Pharmaceuticals
Phase 3 Completed
NCT02733068 2022-12-19
A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.
Shanghai Zerun Biotechnology Co.,Ltd
Phase 3 Completed
NCT02330471 2022-07-08
CONE-1
Ruhr University of Bochum
Phase 3 Completed
NCT00000758 2021-11-04
A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 3 Completed
NCT00001073 2021-11-04
Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 3 Completed
NCT00577317 2021-06-23
Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer
GOG Foundation
Phase 3 Terminated
NCT04646954 2020-11-30
DNA Methylation Testing for the Screening of Uterine Cervical Lesion
Peking Union Medical College Hospital
Phase 3 Unknown
NCT03355820 2020-11-19
A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study
GlaxoSmithKline
Phase 3 Completed
NCT03848039 2020-11-05
HOPE9
Azienda USL Toscana Nord Ovest
Phase 3 Not yet recruiting
NCT01735006 2020-02-24
Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine
Xiamen University
Phase 3 Completed
NCT00128661 2019-03-08
Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants
GlaxoSmithKline
Phase 3 Completed
NCT01131312 2018-11-20
Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS)
National Institutes of Health Clinical Center (CC)
Phase 3 Completed
NCT00003075 2018-10-24
Fenretinide in Treating Patients With Cervical Neoplasia
M.D. Anderson Cancer Center
Phase 3 Completed
NCT02346227 2018-10-12
KINVAV
Universiteit Antwerpen
Phase 3 Completed
NCT02562508 2018-08-16
A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls
Xiamen University
Phase 3 Completed
NCT02329171 2018-08-15
TOPIC
Maastricht University Medical Center
Phase 3 Terminated
NCT02669459 2018-02-06
TopIC-2
Erasmus Medical Center
Phase 3 Unknown
NCT00337818 2017-05-30
Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women
GlaxoSmithKline
Phase 3 Completed
NCT00212381 2017-03-29
Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia
New York Presbyterian Hospital
Phase 3 Completed
NCT00973362 2017-01-06
Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System
Gen-Probe, Incorporated
Phase 3 Completed
NCT01283763 2016-11-01
ITIC2
Medical University of Vienna
Phase 3 Terminated
NCT00929526 2016-10-20
Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study
GlaxoSmithKline
Phase 3 Completed
NCT00529464 2016-05-09
Spectroscopy Versus Standard Care in Cervical Cancer Patients
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT01929993 2015-07-23
A Trial of Two Electrosurgical Conizations: Histopathological Analysis of Excision Margins
Oswaldo Cruz Foundation
Phase 3 Completed
NCT00995020 2015-07-10
Efficacy Study of Diathermy Cone Biopsy for the Treatment of Cervical Intraepithelial Lesion
Oswaldo Cruz Foundation
Phase 3 Completed
NCT00233727 2015-07-09
SAT
Columbia University
Phase 3 Terminated
NCT00462813 2013-08-07
Diindolylmethane in Treating Patients With Abnormal Cervical Cells
National Cancer Institute (NCI)
Phase 3 Completed
NCT01505920 2013-01-15
Lidocaine Spray Compared With Submucosal Injection During LEEP: a Randomized Controlled Trial
Chiang Mai University
Phase 3 Completed
NCT00316706 2012-09-18
Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine
GlaxoSmithKline
Phase 3 Completed
NCT01014026 2011-05-13
APACHE-1
University Hospital, Tours
Phase 3 Completed
NCT00156026 2009-01-29
Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1
Ontario Clinical Oncology Group (OCOG)
Phase 3 Completed
NCT00237562 2006-05-05
Feasibility of the Management of Severe Cervical Dysplasia in a Single Visit
University of California, Irvine
Phase 3 Completed